Biography
My group is interested in identifying why obese individuals are at greater risk of liver injury in the setting of trauma or surgery. My long-term goal is to understand the relationship between metabolic and immunologic processes in the liver. One potential link between these underlying mechanisms could be the peptide leptin, which can profoundly modify inflammatory and metabolic pathways. The goal of this research effort is to improve understanding of the impact of leptin on acute inflammatory cascade and metabolic response during hepatic ischemia-reperfusion. This will benefit patients by improving risk-stratification of candidates for hepatic surgery and possibly lead to preventive therapies for ischemia-reperfusion injury.
Education
- 1986-93, Ludwig-Maximilians University, Munich, Germany, M.D.
- 1993-94 Intern ; City Hospital St. Georg,, University of Hamburg, Germany and Klinikum Grosshadern, Ludwig-Maximilians University, Munich, Germany
- 1996-99, University of California, San Francisco, Resident, Anesthesia
- 1994-96, Department of Anesthesiology, Northwestern University, Chicago, Illinois, Fellow, Postdoctoral Research
Board Certifications
- American Board of Anesthesiology
Clinical Expertise
Pancreas Transplantation
Liver Transplantation
Kidney Transplantation
Clinical Trials
- Intensive Insulin Therapy in Deceased Donors (NCT01140035)Related Conditions: Kidney Transplant, Transplants| Start Date: | End Date:
Program Affiliations
- Department of Anesthesia and Perioperative Care
- Department of Surgery, Division of Transplantation
- UCSF Liver Center
In the News
Research Narrative
My group is interested in identifying why obese individuals are at greater risk of liver injury in the setting of trauma or surgery. My long-term goal is to understand the relationship between metabolic and immunologic processes in the liver. One potential link between these underlying mechanisms could be the peptide leptin, which can profoundly modify inflammatory and metabolic pathways. The goal of this research effort is to improve understanding of the impact of leptin on acute inflammatory cascade and metabolic response during hepatic ischemia-reperfusion. This will benefit patients by improving risk-stratification of candidates for hepatic surgery and possibly lead to preventive therapies for ischemia-reperfusion injury.
Research Interests
Inflammatory response to injuryIschemia reperfusion injury
Liver transplantation
Metabolomics
Organ donation
Renal and hepatic injury during surgery
Intensive Insulin Therapy in Deceased Donors-to improve renal allograft function and transplanted allograft outcomes
View Research Profile at UCSF Clinical & Translational Science Institute
Publications
- Machine Learning Prediction of Liver Allograft Utilization From Deceased Organ Donors Using the National Donor Management Goals Registry.| | PubMed
- Enhanced recovery after surgery programs improve short-term outcomes after liver transplantation-A systematic review and meta-analysis.| | PubMed
- Assessment of the global practice of living donor liver transplantation.| | PubMed
- Raster Thomson scattering in large-scale laser plasmas produced at high repetition rate.| | PubMed
- Critical care and ventilatory management of deceased organ donors impact lung use and recipient graft survival.| | PubMed
- Shared B cell memory to coronaviruses and other pathogens varies in human age groups and tissues.| | PubMed
- Prospective Multicenter Study of Early Antiviral Therapy in Liver and Kidney Transplant Recipients of HCV-Viremic Donors.| | PubMed
- Weighing the waitlist: Weight changes and access to kidney transplantation among obese candidates.| | PubMed
- COVID-19 and Abdominal Transplant: A Stepwise Approach to Practice During Pandemic Conditions.| | PubMed
- The Association Between Vena Cava Implantation Technique and Acute Kidney Injury After Liver Transplantation.| | PubMed